Prevnar 13 2.2 mcg (Pneumococcal Polysaccharide Serotype 14 SUSPENSION) 2.2 MCG

PREVNAR 13 2.2 MCG is a pneumococcal vaccine designed to protect against pneumococcal disease. This suspension is administered intramuscularly and is manufactured by Pfizer Canada ULC.

Strength

2.2 MCG

Pack Size

1 PRE-FILLED SYR/10 PRE-FILL SYR

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PREVNAR 13 2.2 MCG is used to help prevent pneumococcal disease caused by the pneumococcal polysaccharide serotype 14. This vaccine is typically recommended for individuals who are at increased risk of pneumococcal infection, such as young children and adults with certain medical conditions. It works by stimulating the body's immune system to produce antibodies against the pneumococcus bacteria, which can help prevent infection.

Side Effects

Common effects of PREVNAR 13 2.2 MCG may include redness, swelling, or pain at the injection site. Some individuals may also experience mild fever, fatigue, or headache after receiving the vaccine. These effects are usually temporary and resolve on their own within a few days.

Precautions & Warnings

Before receiving PREVNAR 13 2.2 MCG, inform your healthcare provider about any allergies, especially to any components of the vaccine. It is important to discuss your medical history, including any recent illnesses or immunizations. The vaccine should be stored and handled according to the manufacturer's guidelines to ensure its effectiveness.

Avoid Interactions

PREVNAR 13 2.2 MCG may interact with other medications or vaccines. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, supplements, and other vaccines. Alcohol and certain medications may affect the immune response to the vaccine, so it is advisable to discuss any potential interactions with a healthcare professional.

Frequently Asked Questions

PREVNAR 13 2.2 MCG is used to help prevent pneumococcal disease caused by the pneumococcal polysaccharide serotype 14.

PREVNAR 13 2.2 MCG is administered intramuscularly, typically in the upper arm or thigh.

Common side effects may include redness, swelling, or pain at the injection site, as well as mild fever, fatigue, or headache.

Individuals with a known allergy to any component of the vaccine should not receive PREVNAR 13 2.2 MCG. Consult a healthcare provider for personalized advice.

It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.